These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11805224)

  • 1. Mechanisms of action of antiarrhythmic agent bertosamil on hKv1.5 channels and outward potassium current in human atrial myocytes.
    Godreau D; Vranckx R; Hatem SN
    J Pharmacol Exp Ther; 2002 Feb; 300(2):612-20. PubMed ID: 11805224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiarrhythmic agent bertosamil induces inactivation of the sustained outward K+ current in human atrial myocytes.
    Tessier S; Rücker-Martin C; Macé L; Coraboeuf E; Mercadier JJ; Hatem SN
    Br J Pharmacol; 1997 Sep; 122(2):291-301. PubMed ID: 9313938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bertosamil blocks HERG potassium channels in their open and inactivated states.
    Zitron E; Karle CA; Wendt-Nordahl G; Kathöfer S; Zhang W; Thomas D; Weretka S; Kiehn J
    Br J Pharmacol; 2002 Sep; 137(2):221-8. PubMed ID: 12208779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
    Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of bepridil on hKv1.5 channel current: comparison with amiodarone and E-4031.
    Kobayashi S; Reien Y; Ogura T; Saito T; Masuda Y; Nakaya H
    Eur J Pharmacol; 2001 Nov; 430(2-3):149-57. PubMed ID: 11711026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein.
    Zhang ZH; Wang Q
    Pflugers Arch; 2000 Sep; 440(5):784-92. PubMed ID: 11007322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
    Choe H; Lee YK; Lee YT; Choe H; Ko SH; Joo CU; Kim MH; Kim GS; Eun JS; Kim JH; Chae SW; Kwak YG
    J Pharmacol Exp Ther; 2003 Feb; 304(2):706-12. PubMed ID: 12538825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking characteristics of hKv1.5 and hKv4.3/hKChIP2.2 after administration of the novel antiarrhythmic compound AZD7009.
    Persson F; Carlsson L; Duker G; Jacobson I
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):7-17. PubMed ID: 15965349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.
    Gögelein H; Brendel J; Steinmeyer K; Strübing C; Picard N; Rampe D; Kopp K; Busch AE; Bleich M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):183-92. PubMed ID: 15340774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
    Perchenet L; Clément-Chomienne O
    J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External nickel blocks human Kv1.5 channels stably expressed in CHO cells.
    Perchenet L; Clément-Chomienne O
    J Membr Biol; 2001 Sep; 183(1):51-60. PubMed ID: 11547352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
    Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
    Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
    J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents.
    Choi BH; Park JA; Kim KR; Lee GI; Lee YT; Choe H; Ko SH; Kim MH; Seo YH; Kwak YG
    Am J Physiol Cell Physiol; 2005 Aug; 289(2):C425-36. PubMed ID: 15800051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
    Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
    Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5).
    Delpón E; Caballero R; Valenzuela C; Longobardo M; Snyders D; Tamargo J
    Cardiovasc Res; 1999 May; 42(2):510-20. PubMed ID: 10533586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
    Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
    Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
    Kojima A; Ito Y; Ding WG; Kitagawa H; Matsuura H
    Eur J Pharmacol; 2015 Oct; 764():622-632. PubMed ID: 26256861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3.
    Choi JS; Hahn SJ; Rhie DJ; Yoon SH; Jo YH; Kim MS
    J Pharmacol Exp Ther; 1999 Oct; 291(1):1-6. PubMed ID: 10490879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers.
    Valenzuela C; Delpón E; Tamkun MM; Tamargo J; Snyders DJ
    Biophys J; 1995 Aug; 69(2):418-27. PubMed ID: 8527655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.